CA
NZ
UK
AU
IND
US
● About 911.5 million insider shares are set to be released from lockup.
TCGX Acquisition Corp. II (NASDAQ:TCXB) closed at $10.86 on Friday, October 16, 2026, a gain of 8.60% from its $10.00 offering price on its first day of trading on the Nasdaq. The special purpose acquisition company priced its initial public offering of 10 million …
● Only 10 million shares were new, worth roughly $180 million gross.
No October 14 company announcement was identified to explain BSP’s 35.34% rise. Bending Spoons listed on July 1, 2026 at USD 29, above its marketed USD 26 to USD 28 range, and the shares have since moved well beyond the offering price. Because the …
No company announcement dated October 14, 2026 was found, so the 35.34% advance has no stated trigger. The company went public on July 1, 2026 at USD 29, above a marketed range of USD 26 to USD 28, and the shares have since traded …
Retension Pharma (NASDAQ:RTSN) announced the pricing of an upsized IPO on October 8, 2026, selling 3.75 million shares at USD 12.00. The offering totals USD 45 million before discounts and expenses, simple arithmetic, which matches the figure in the topics file. Trading is expected …
Retension Pharma (NASDAQ:RTSN) priced an upsized IPO on October 8, 2026, selling 3.75 million shares at USD 12.00 for gross proceeds of USD 45 million, simple arithmetic that matches the pricing release. Trading is expected from October 9 and closing on October 13. Upsizing …
TRex Bio, a biotech focused on autoimmune and inflammatory diseases, filed terms on October 5, 2026 to list onNasdaqunder the proposed ticker TRXB. The deal is 8.33 million shares at USD 14 to USD 16. At the USD 15 midpoint that raises about USD …
Retension Pharmaceuticals plans to list on theNasdaqCapital Market under the ticker RTSN. The amended S-1 offers 3,300,000 common shares at USD 11 to USD 13, with a 30-day option for the underwriters to buy 495,000 more. At the USD 12 midpoint, gross proceeds are …
TRex Bio, an autoimmune and inflammatory disease biotech, filed terms on October 5, 2026 to list onNasdaqunder the proposed ticker TRXB. The offering is 8.33 million shares at USD 14 to USD 16, raising about USD 124.95 million at the USD 15 midpoint, simple …
Please wait processing your request...